Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
Thomas Ernst, Andrew Chase, Joannah Score, et al.
Nature Genetics (2010) Vol. 42, Iss. 8, pp. 722-726
Closed Access | Times Cited: 1108

Showing 26-50 of 1108 citing articles:

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet
Luca Malcovati, Eva Hellström‐Lindberg, David Bowen, et al.
Blood (2013) Vol. 122, Iss. 17, pp. 2943-2964
Open Access | Times Cited: 635
Evolution of the cancer genome
Lucy Yates, Peter J. Campbell
Nature Reviews Genetics (2012) Vol. 13, Iss. 11, pp. 795-806
Open Access | Times Cited: 617
RNA splicing factors as oncoproteins and tumour suppressors
Heidi Dvinge, Eun Hee Kim, Omar Abdel‐Wahab, et al.
Nature reviews. Cancer (2016) Vol. 16, Iss. 7, pp. 413-430
Open Access | Times Cited: 603
Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms
Pontus Lundberg, Axel Karow, Ronny Nienhold, et al.
Blood (2014) Vol. 123, Iss. 14, pp. 2220-2228
Open Access | Times Cited: 577
Recurrent mutations in the U2AF1 splicing factor in myelodysplastic syndromes
Timothy A. Graubert, Dong Shen, Li Ding, et al.
Nature Genetics (2011) Vol. 44, Iss. 1, pp. 53-57
Open Access | Times Cited: 560
Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice
Myunggon Ko, Hozefa S. Bandukwala, Jungeun An, et al.
Proceedings of the National Academy of Sciences (2011) Vol. 108, Iss. 35, pp. 14566-14571
Open Access | Times Cited: 554
PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors
William Lee, Sewit Teckie, Thomas Wiesner, et al.
Nature Genetics (2014) Vol. 46, Iss. 11, pp. 1227-1232
Open Access | Times Cited: 550
ASXL1 Mutations Promote Myeloid Transformation through Loss of PRC2-Mediated Gene Repression
Omar Abdel‐Wahab, Mazhar Adli, Lindsay M. LaFave, et al.
Cancer Cell (2012) Vol. 22, Iss. 2, pp. 180-193
Open Access | Times Cited: 549
Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host
Winston Timp, Andrew P. Feinberg
Nature reviews. Cancer (2013) Vol. 13, Iss. 7, pp. 497-510
Open Access | Times Cited: 548
Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms
William Vainchenker, Róbert Královics
Blood (2016) Vol. 129, Iss. 6, pp. 667-679
Open Access | Times Cited: 531
Recurrent DNMT3A mutations in patients with myelodysplastic syndromes
Matthew J. Walter, Li Ding, Dong Shen, et al.
Leukemia (2011) Vol. 25, Iss. 7, pp. 1153-1158
Open Access | Times Cited: 524
Aberrations of EZH2 in Cancer
Andrew Chase, Nicholas C.P. Cross
Clinical Cancer Research (2011) Vol. 17, Iss. 9, pp. 2613-2618
Open Access | Times Cited: 515
Genetic inactivation of the polycomb repressive complex 2 in T cell acute lymphoblastic leukemia
Panagiotis Ntziachristos, Aristotelis Tsirigos, Pieter Van Vlierberghe, et al.
Nature Medicine (2012) Vol. 18, Iss. 2, pp. 298-302
Open Access | Times Cited: 507
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
Raphaël Itzykson, Olivier Kosmider, Aline Renneville, et al.
Journal of Clinical Oncology (2013) Vol. 31, Iss. 19, pp. 2428-2436
Open Access | Times Cited: 505
SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition
Eun Hee Kim, Janine O. Ilagan, Yang Liang, et al.
Cancer Cell (2015) Vol. 27, Iss. 5, pp. 617-630
Open Access | Times Cited: 503
Emerging patterns of somatic mutations in cancer
Ian R. Watson, Koichi Takahashi, P. Andrew Futreal, et al.
Nature Reviews Genetics (2013) Vol. 14, Iss. 10, pp. 703-718
Open Access | Times Cited: 484
EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas
Faizaan Mohammad, Simon Weissmann, Benjamin Leblanc, et al.
Nature Medicine (2017) Vol. 23, Iss. 4, pp. 483-492
Closed Access | Times Cited: 468
Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)
Michael T. McCabe, Alan P. Graves, Gopinath Ganji, et al.
Proceedings of the National Academy of Sciences (2012) Vol. 109, Iss. 8, pp. 2989-2994
Open Access | Times Cited: 464
Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias
Raphaël Itzykson, Olivier Kosmider, Thomas Cluzeau, et al.
Leukemia (2011) Vol. 25, Iss. 7, pp. 1147-1152
Closed Access | Times Cited: 450
The roles of DNA, RNA and histone methylation in ageing and cancer
Ewa M. Michalak, Marian L. Burr, Andrew J. Bannister, et al.
Nature Reviews Molecular Cell Biology (2019) Vol. 20, Iss. 10, pp. 573-589
Open Access | Times Cited: 446
RUNX1 Mutations in Acute Myeloid Leukemia: Results From a Comprehensive Genetic and Clinical Analysis From the AML Study Group
Verena I. Gaidzik, Lars Bullinger, Richard F. Schlenk, et al.
Journal of Clinical Oncology (2011) Vol. 29, Iss. 10, pp. 1364-1372
Open Access | Times Cited: 438
Landscape Of Genetic Lesions In 944 Patients With Myelodysplastic Syndromes
Yasunobu Nagata, Vera Grossmann, Yusuke Okuno, et al.
Blood (2013) Vol. 122, Iss. 21, pp. 521-521
Open Access | Times Cited: 431
PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies
Thomas De Raedt, Eline Beert, Éric Pasmant, et al.
Nature (2014) Vol. 514, Iss. 7521, pp. 247-251
Closed Access | Times Cited: 426
Chromatin proteins and modifications as drug targets
Kristian Helin, Dashyant Dhanak
Nature (2013) Vol. 502, Iss. 7472, pp. 480-488
Closed Access | Times Cited: 401
Maintaining cell identity: PRC2-mediated regulation of transcription and cancer
Itys Comet, Eva M. Riising, Benjamin Leblanc, et al.
Nature reviews. Cancer (2016) Vol. 16, Iss. 12, pp. 803-810
Closed Access | Times Cited: 400

Scroll to top